… compared vascular risk factors for stroke … risk factors; there were no significant clinical or
paraclinical differences between these patients and those without antiphospholipid antibodies. …

… [6, 33 – 36], well-designed prospective studies should address should address the role of
antiphospholipid antibodies as risk factors for adverse events and potential therapeutic …

… In 2003, two systematic reviews of the literature on LA, aCL, aβ2GPI, and aPT antibodies
showed that LAs are the strongest risk factors for both arterial and venous thrombosis, whereas …

… However, the risk factors for thrombosis and the optimal treatment of the syndrome are
still uncertain. To obtain more information on the clinical features of APS, a Registry of APA …

… of antiphospholipid antibodies (aPL), including anticardiolipin antibodies (aCL), anti-β 2 -glycoprotein
I antibodies … Furthermore, we investigated additional clinical risk factors associated …

… had a combination of risk factors with APL, 10 had only one risk factor and seven patients had
… The frequency of acquired thrombophilia markers and risk factors in controls and patients …

… antiphospholipid syndrome, lupus anticoagulant, anticardiolipin and anti-β2 glycoprotein I
antibody assays are independent risk factors … different antiphospholipid antibody profiles in the …

… The presence of antiphospholipid antibodies is a risk factor for thrombosis; consequently,
the prevalence of antiphospholipid antibodies is higher in individuals with thrombotic or …

… risk of recurrent thrombosis among patients with an antiphospholipid antibody is very low. …
There were inadequate data to assess APLA as a risk factor for bleeding, development of the …

… Antiphospholipid antibodies are an indepen- dent risk factor for stroke in young adults in five
… The best therapeutic strategy for preventing antiphospholipid antibody-associated recurrent …